ClinicalTrials.gov
ClinicalTrials.gov Menu

Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00116961
Recruitment Status : Completed
First Posted : July 1, 2005
Last Update Posted : February 7, 2012
Sponsor:
Information provided by:
University of Michigan Cancer Center